Selvaraju Veeriah

Immunology and Microbiology · Life Sciences

39h-index14.3kcitations185works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(54), Cancer Immunotherapy and Biomarkers(51), Cancer Genomics and Diagnostics(45), Immune cells in cancer(26), Lung Cancer Treatments and Mutations(22)

Publications176 total

Retracted - Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
The Francis Crick Institute·2026Open Access
Somatic evolution following cancer treatment in normal tissue
Nature·2025Open Access
Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma
Genome biology·2025Open Access
Table S2 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
2025Open Access
Table S1 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
2025Open Access
Supplementary Data from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
2025Open Access
Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction
Cell·2025· 3 citedOpen Access
152P Association of genetic intra-tumour heterogeneity with outcome in TRACERx
Annals of Oncology·2025
DNA methylation cooperates with genomic alterations during non-small cell lung cancer evolution
Nature Genetics·2025· 4 citedOpen Access
Subclonal immune evasion in non-small cell lung cancer
Cancer Cell·2025· 12 citedOpen Access
Abstract 1207: The evolution of immunity and immune evasion from early- to end-stage lung cancer
Cancer Research·2025
Abstract 6421: Tracking the evolution of non-small-cell lung cancer: Completion of the TRACERx longitudinal cohort
Cancer Research·2025
Clonal driver neoantigen loss under EGFR TKI and immune selection pressures
Nature·2025· 14 citedOpen Access
ImmuneLENS characterizes systemic immune dysregulation in aging and cancer
Nature Genetics·2025· 6 citedOpen Access
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma
Nature Cancer·2025· 7 citedOpen Access
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
Nature Medicine·2025· 52 citedOpen Access
128P Metastatic migrations in lung cancer: Insights from the PEACE autopsy programme
ESMO Open·2024Open Access
90P Clinical phenotyping of lung cancer-associated cachexia in relation to tumour volume in TRACERx
ESMO Open·2024Open Access
59P Identifying blood-based proteomic mediators of cancer-associated cachexia in non-small cell lung cancer in the TRACERx study
ESMO Open·2024Open Access
Table S2 from Spatial positioning of immune hotspots reflects the interplay between B and T cells in lung squamous cell carcinoma
2024Open Access
page 1 of 9Next →

Frequent Co-authors

Nicholas McGranahan(27), Mariam Jamal‐Hanjani(26), Nicolai J. Birkbak(26), Maise Al Bakir(26), Crispin T. Hiley(25), Sophia Ward(25), David A. Moore(23), Sergio A. Quezada(23), Charles Swanton(23), Peter Van Loo(22), Gareth A. Wilson(21), Rachel Rosenthal(21), Thomas B.K. Watkins(18), Allan Hackshaw(18), Kevin Litchfield(18), Ariana Huebner(18), Teresa Marafioti(17), Andrew Rowan(16), Dean A. Fennell(16), Cristina Naceur‐Lombardelli(16)